Disease-modifying anti-Rheumatic Drugs and Immunosuppressants MSS3
Medication Safety Series: MSS 3 - Disease-modifying anti-Rheumatic Drugs and Immunosuppressants. This covers On-Admission, During-Admission and On Discharge / prolonged leave.
We know that some of our PDF documents may not be accessible to everyone but we’re working on it. As documents come up for renewal we aim to make them more accessible. In the meantime, if you need any of our policies in a different format please email [email protected]
Showing 109 Publications filtered by Pharmacy
-
-
Patient group direction Infuenza vaccine
This document outlines all staff procedures regarding the flu vaccine.
Category: Procedures
Topic: Pharmacy
-
Shared care guidelines first generation antipsychotic long acting injections
This document outlines all the information needed to prescribe this injection. Which medical condition and doses required.
Category: Procedures
Topic: Pharmacy
-
Shared care guidelines dexamfetamine
This document contains all the information needed about the drug dexamfetamine and which medical condition patients can be prescribed to this.
Category: Procedures
Topic: Pharmacy
-
Safe transfer of prescribing guidance
Safe transfer of prescribing guidance supports safe transfer of prescribing from TEWV doctor to patient's own GP primary care services.
Category: Guidance
Topic: Pharmacy
-
Valproate shared care guidelines
This document can to be used as a guideline to prescribing valproate.
Category: Procedures
Topic: Pharmacy
-
Psychotropic medication monitoring guide
Guidance for the monitoring of psychotropic medication.
Category: Procedures
Topic: Pharmacy
-
Methadone buprenorphine in patient prescribing guideline
The aim of this document is to provide guidance to doctors and other clinicians on the prescribing aspects of methadone or buprenorphine.
Category: Procedures
Topic: Pharmacy
-
Shared care guideline melatonin
These documents are used as guidelines for treatment to establish a healthy sleep pattern with the lowest effective dose of melatonin. There are two versions to reflect slightly different commissioning arrangements for melatonin in each of our two care group areas.
Category: Guidance
Topic: Pharmacy
-
Shared care guidelines lisdexamfetamine
This document is a guideline to the information needed to prescribe lisdexamfetamine a CNS stimulant licensed for the treatment of ADHD in children aged 6-17.
Category: Procedures
Topic: Pharmacy
